Zoledronic acid is a bisphosphonate used to treat bone disorders including Pagets disease, osteoporosis, and malignancy-related hypercalcemia. It is widely applied in oncology and bone metabolism research, with studies demonstrating its efficacy in inhibiting osteoclast-mediated bone resorption in both in vitro and in vivo models.